BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 28717180)

  • 1. A three miRNAs signature predicts survival in cervical cancer using bioinformatics analysis.
    Liang B; Li Y; Wang T
    Sci Rep; 2017 Jul; 7(1):5624. PubMed ID: 28717180
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Three-microRNA signature identified by bioinformatics analysis predicts prognosis of gastric cancer patients.
    Zhang C; Zhang CD; Ma MH; Dai DQ
    World J Gastroenterol; 2018 Mar; 24(11):1206-1215. PubMed ID: 29568201
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrative miRNA analysis identifies hsa-miR-3154, hsa-miR-7-3, and hsa-miR-600 as potential prognostic biomarker for cervical cancer.
    Zeng Y; Wang KX; Xu H; Hong Y
    J Cell Biochem; 2018 Feb; 119(2):1558-1566. PubMed ID: 28771797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Role of Significantly Deregulated MicroRNAs in Recurrent Cervical Cancer Based on Bioinformatic Analysis of the Cancer Genome Atlas Data.
    Liu H; Liu L; Zhu H
    J Comput Biol; 2019 Apr; 26(4):387-395. PubMed ID: 30762435
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel three‑miRNA signature predicts survival in cholangiocarcinoma based on RNA‑Seq data.
    Cao J; Sun L; Li J; Zhou C; Cheng L; Chen K; Yan B; Qian W; Ma Q; Duan W
    Oncol Rep; 2018 Sep; 40(3):1422-1434. PubMed ID: 29956786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Novel Three-miRNA Signature Identified Using Bioinformatics Predicts Survival in Esophageal Carcinoma.
    Wu K; Zhang C; Zhang C; Dai D
    Biomed Res Int; 2020; 2020():5973082. PubMed ID: 32104700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MicroRNA expression in cervical cancer: Novel diagnostic and prognostic biomarkers.
    Gao C; Zhou C; Zhuang J; Liu L; Liu C; Li H; Liu G; Wei J; Sun C
    J Cell Biochem; 2018 Aug; 119(8):7080-7090. PubMed ID: 29737570
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A microRNA-Messenger RNA Regulatory Network and Its Prognostic Value in Cervical Cancer.
    Liu J; Yang J; Gao F; Li S; Nie S; Meng H; Sun R; Wan Y; Jiang Y; Ma X; Cheng W
    DNA Cell Biol; 2020 Jul; 39(7):1328-1346. PubMed ID: 32456463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel microRNAs expression signature for hepatocellular carcinoma diagnosis and prognosis.
    Lu M; Kong X; Wang H; Huang G; Ye C; He Z
    Oncotarget; 2017 Jan; 8(5):8775-8784. PubMed ID: 28060739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identifying a new microRNA signature as a prognostic biomarker in colon cancer.
    Lv Y; Duanmu J; Fu X; Li T; Jiang Q
    PLoS One; 2020; 15(2):e0228575. PubMed ID: 32049961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Three differential expression profiles of miRNAs as potential biomarkers for lung adenocarcinoma.
    Zheng R; Mao W; Du Z; Zhang J; Wang M; Hu M
    Biochem Biophys Res Commun; 2018 Dec; 507(1-4):377-382. PubMed ID: 30442364
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A five-miRNA signature predicts survival in gastric cancer using bioinformatics analysis.
    Zhang Z; Dong Y; Hua J; Xue H; Hu J; Jiang T; Shi L; Du J
    Gene; 2019 May; 699():125-134. PubMed ID: 30849543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miRNA-21 and miRNA-223 expression signature as a predictor for lymph node metastasis, distant metastasis and survival in kidney renal clear cell carcinoma.
    Yu L; Xiang L; Feng J; Li B; Zhou Z; Li J; Lin Y; Lv Y; Zou D; Lei Z; Zhang J
    J Cancer; 2018; 9(20):3651-3659. PubMed ID: 30405833
    [No Abstract]   [Full Text] [Related]  

  • 14. Identification of miRNA-mRNA Regulatory Network and Construction of Prognostic Signature in Cervical Cancer.
    Mei Y; Jiang P; Shen N; Fu S; Zhang J
    DNA Cell Biol; 2020 Jun; 39(6):1023-1040. PubMed ID: 32349536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Optimal subset of signature miRNAs consisting of 7 miRNAs that can serve as a novel diagnostic and prognostic predictor for the progression of cervical cancer.
    Shi C; Yang Y; Zhang L; Zhang T; Yu J; Qin S; Gao Y
    Oncol Rep; 2019 Jun; 41(6):3167-3178. PubMed ID: 30942460
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification and validation of a miRNA-based prognostic signature for cervical cancer through an integrated bioinformatics approach.
    Qi Y; Lai YL; Shen PC; Chen FH; Lin LJ; Wu HH; Peng PH; Hsu KW; Cheng WC
    Sci Rep; 2020 Dec; 10(1):22270. PubMed ID: 33335254
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer.
    Ma D; Zhang YY; Guo YL; Li ZJ; Geng L
    Chin Med J (Engl); 2012 Dec; 125(23):4270-6. PubMed ID: 23217399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A tumor-specific microRNA signature predicts survival in clear cell renal cell carcinoma.
    Ge YZ; Wu R; Xin H; Zhu M; Lu TZ; Liu H; Xu Z; Yu P; Zhao YC; Li MH; Hu ZK; Zhao Y; Zhong B; Xu X; Zhou LH; Xu LW; Wu JP; Li WC; Zhu JG; Jia RP
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1291-9. PubMed ID: 25633718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma miRNAs in diagnosis and prognosis of pancreatic cancer: A miRNA expression analysis.
    Zhou X; Lu Z; Wang T; Huang Z; Zhu W; Miao Y
    Gene; 2018 Oct; 673():181-193. PubMed ID: 29913239
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Seven protective miRNA signatures for prognosis of cervical cancer.
    Liu B; Ding JF; Luo J; Lu L; Yang F; Tan XD
    Oncotarget; 2016 Aug; 7(35):56690-56698. PubMed ID: 27447860
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.